To generate a non-invasive method for evaluating the risk degree for patients with atherosclerotic disease, to suffer a stroke or myocardial infarction, scientists used nanobodies coupled with lipid-shelled decaflurobutane microbubbles to evaluate VCAM-1 expression, using contrast-enhanced ultrasound molecular imaging (CEUMI). This evidence concerns the gene VCAM1 and stroke disorder.